Background: In Italy, cervical cancer screening programmes actively invite women aged 25–
64 years. Programmes are hindered by low participation. Methods: A sample of non …

This article provides an overview of cervical cancer and other human papillomavirus (HPV)-
related diseases in Central and Eastern Europe (Albania, Bosnia and Herzegovina …

Background Cervical cancer incidence remains high in several Baltic, central, and eastern
European (BCEE) countries, mainly as a result of a historical absence of effective screening …

Background: Cervical cancer screening coverage remains insufficient in most countries. Our
objective was to assess whether in-home vaginal self-sampling with a dry swab for high-risk …

Cervical cancer is relatively rare in high‐income countries, where organized screening
programs are in place, as well as opportunistic ones. As the human papillomavirus (HPV) …

Cervical cancer is the second most common and the fifth deadliest cancer in women. In this
paper, we propose a deep learning approach for detecting cervix cancer from pap-smear …

Objective To compare the detection rates of precancerous and cancerous cervical lesions by
human papillomavirus (HPV) DNA testing and by conventional cytology screening. Design …

Background Women treated for high-grade cervical intraepithelial neoplasia (grade 2 or 3)
are at elevated risk for developing cervical cancer. Suggested factors identifying women at …

High‐grade cervical intraepithelial neoplasia (CIN2 and CIN3) represents a heterogeneous
disease with varying cancer progression risks. Biomarkers indicative for a productive human …

This comprehensive review compiles published data from 62 original articles comparing
different HPV tests and one meta-analysis on the clinical performance of the Aptima HR HPV …